Raymond James Has Pessimistic Outlook of TSE:ATR Q4 Earnings

SNC-Lavalin Group Inc. (TSE:ATRFree Report) – Research analysts at Raymond James dropped their Q4 2024 earnings estimates for SNC-Lavalin Group in a report issued on Thursday, November 14th. Raymond James analyst F. Bastien now expects that the company will post earnings per share of $0.59 for the quarter, down from their prior forecast of $0.62. Raymond James also issued estimates for SNC-Lavalin Group’s Q3 2025 earnings at $0.77 EPS and FY2025 earnings at $2.80 EPS.

SNC-Lavalin Group Price Performance

SNC-Lavalin Group Company Profile

(Get Free Report)

AptarGroup, Inc provides a range of dispensing, sealing, and material science solutions primarily for the beauty, personal care, home care, prescription drug, consumer health care, injectable, and food and beverage markets. The company operates through three segments: Pharma, Beauty + Home, and Food + Beverage.

Featured Stories

Earnings History and Estimates for SNC-Lavalin Group (TSE:ATR)

Receive News & Ratings for SNC-Lavalin Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SNC-Lavalin Group and related companies with MarketBeat.com's FREE daily email newsletter.